Filing intellectual property on novel targets and epitopes

Understanding intellectual property is crucial in today’s competitive landscape, and it is essential for the development and success of the biotech ventures. However, for emerging companies, building an IP portfolio can be a challenging task, and it is particularly tricky if one wants to file intellectual property around novels targets and epitopes. 

Join this BaseLaunch event together with Vossius & Partner and have the opportunity to learn more about IP strategy on new targets and epitopes, understanding the importance of precise identification and characterization of epitopes, how to develop a commercial strategy for epitope IP and much more.

Join the conversation on our LinkedIn page or submit your questions through this form.

This event is powered by Innosuisse.